- Home
- NTRB vs BAFN Comparison
NTRB vs BAFN Comparison
Compare NTRB & BAFN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NTRB
- BAFN
- Stock Information
- Founded
- NTRB 2016
- BAFN 1999
- Country
- NTRB United States
- BAFN United States
- Employees
- NTRB N/A
- BAFN N/A
- Industry
- NTRB Industrial Specialties
- BAFN Savings Institutions
- Sector
- NTRB Health Care
- BAFN Finance
- Exchange
- NTRB Nasdaq
- BAFN Nasdaq
- Market Cap
- NTRB 46.4M
- BAFN 55.4M
- IPO Year
- NTRB N/A
- BAFN N/A
- Fundamental
- Price
- NTRB $4.11
- BAFN $13.75
- Analyst Decision
- NTRB
- BAFN
- Analyst Count
- NTRB 0
- BAFN 0
- Target Price
- NTRB N/A
- BAFN N/A
- AVG Volume (30 Days)
- NTRB 26.3K
- BAFN 3.5K
- Earning Date
- NTRB 12-04-2024
- BAFN 01-30-2025
- Dividend Yield
- NTRB N/A
- BAFN 2.33%
- EPS Growth
- NTRB N/A
- BAFN N/A
- EPS
- NTRB N/A
- BAFN 0.72
- Revenue
- NTRB $2,021,771.00
- BAFN $76,217,000.00
- Revenue This Year
- NTRB N/A
- BAFN N/A
- Revenue Next Year
- NTRB N/A
- BAFN N/A
- P/E Ratio
- NTRB N/A
- BAFN $18.67
- Revenue Growth
- NTRB N/A
- BAFN 7.06
- 52 Week Low
- NTRB $2.22
- BAFN $10.40
- 52 Week High
- NTRB $9.60
- BAFN $15.05
- Technical
- Relative Strength Index (RSI)
- NTRB 44.78
- BAFN 58.58
- Support Level
- NTRB $3.90
- BAFN $13.07
- Resistance Level
- NTRB $5.16
- BAFN $13.40
- Average True Range (ATR)
- NTRB 0.33
- BAFN 0.39
- MACD
- NTRB -0.01
- BAFN 0.03
- Stochastic Oscillator
- NTRB 27.04
- BAFN 99.99
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
About BAFN BayFirst Financial Corp.
BayFirst Financial Corp is a one bank holding company, it generates its revenue from interest on loans and the gain-on-sale income derived from the sale of loans into the secondary market. The company serves a broad spectrum of individuals, families, and small businesses, supported by national business lines in residential and SBA lending and technology platforms. The primary source of funding for its loans is deposits. BayFirst measures performance through net interest income after provision for loan losses, return on average assets, and return on average common equity, while maintaining appropriate regulatory leverage and risk-based capital ratios.